Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04752657 · ClinicalTrials.gov registry record · NA
Second eFramngham Heart Study
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 492
- Enrollment target
NCT04752657 is a NA study that has completed, run by Boston University. The registered enrollment target is 492 participants.
The verdict
NCT04752657, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 492 participants
- Enrollment target
Study Summary
In the electronic Framingham Heart Study (eFHS), the investigators developed and deployed a mobile app to collect cardiovascular risk factors and event data and test them against cardiovascular data collected in the Framingham research clinic for the FHS. Participants enrolled in eFHS receive a series of digital surveys modules to complete on a regularly occurring schedule. The objective of the planned randomized trial is to test the effect of administering half of survey modules every 2 weeks versus all survey modules every 4 weeks on improving participants' response rates. There will be 4 survey periods. Period 1 encompasses all survey modules administered from baseline up to week 8 (19 surveys/tasks per participant); period 2 from week 8 up to week 16 (18 surveys/tasks per participant); period 3 from week 16 up to week 24; period 4 from week 24 (16 surveys/tasks per participant).
Interventions
- OTHER Delayed administration of survey modules
- OTHER Regular administration of survey modules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 492 participants |
| Start Date | 2021-06-21 |
| Est. Completion | 2023-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04752657
The ClinicalTrials.gov registry entry for NCT04752657 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 492 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Delayed administration of survey modules is the first listed.
NCT04752657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04752657 about?
NCT04752657 is a clinical study titled "Second eFramngham Heart Study". In the electronic Framingham Heart Study (eFHS), the investigators developed and deployed a mobile app to collect cardiovascular risk factors and event data and test them against cardiovascular data collected in the Framingham research clinic for the FHS. Participants enrolled in eFHS receive a ser...
What is the current status of trial NCT04752657?
This trial is currently completed. It is a NA study. The enrollment target is 492 participants. The study started on 2021-06-21. Estimated completion is 2023-12-28.
What interventions are being tested in trial NCT04752657?
The interventions under investigation include: Delayed administration of survey modules (OTHER), Regular administration of survey modules (OTHER).
Who is sponsoring clinical trial NCT04752657?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.